AFC
NVO

AFT Forsyth & Company’s Novo Nordisk NVO Stock Holding History

AFT Forsyth & Company’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,125
Closed -$446K – 137
2024
Q2 		$446K Hold
3,125
– – 0.22% 89
2024
Q1 		$401K Hold
3,125
– – 0.23% 93
2023
Q4 		$323K Buy
+3,125
New +$309K 0.2% 105

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AFT Forsyth & Company's NVO Position: Q3 2024 in Review

AFT Forsyth & Company sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 3,125 shares — an estimated $446K sold.

AFT Forsyth & Company first reported a position in NVO in Q4 2023 and held it in 3 quarters. The position peaked at $446K in Q2 2024. 1,785 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • AFT Forsyth & Company reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • AFT Forsyth & Company sold 3,125 Novo Nordisk shares in Q3 2024, an estimated $446K.
  • AFT Forsyth & Company first reported a position in Novo Nordisk in Q4 2023 and held it in 3 quarters.
  • AFT Forsyth & Company's Novo Nordisk position peaked at $446K in Q2 2024.
  • 1,785 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on AFT Forsyth & Company's 13F filing for Q3 2024, filed 14 Nov 2024.